Bioxytran, Inc.
USD0.03
-0.00 (-0.33%)
CEO
David Platt
IPO Date
2010-01-05
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.03
Prev. Close
$0.03
Day Low
$0.03
Day High
$0.03
52W Low
$0.03
52W High
$0.14
Market Cap
$0.00B
Volume
0.06M
| 38,588 |
| $0.35 |
| 18 Nov 2025 | Hoberman Alan M | director | P-Purchase | Acquired | 210,000 | $0.60 |
| 18 Nov 2025 | MILANOVA RADKA | director | A-Award | Acquired | 10,417 | $0.48 |
| 18 Nov 2025 | MILANOVA RADKA | director | A-Award | Acquired | 38,588 | $0.35 |
| 18 Nov 2025 | CONAWAY DALE H | director | A-Award | Acquired | 10,417 | $0.48 |
| 18 Nov 2025 | CONAWAY DALE H | director | A-Award | Acquired | 38,588 | $0.35 |
| 18 Nov 2025 | Utter Anders | director | A-Award | Acquired | 38,588 | $0.35 |
| 18 Nov 2025 | PLATT DAVID | director, 10 percent owner, officer: CEO | J-Other | Disposed | 14,085,410 | $0.28 |
| 18 Nov 2025 | PLATT DAVID | director, 10 percent owner, officer: CEO | J-Other | Acquired | 11,433,448 | $0.55 |